At Gnome, we understand the critical role that preclinical biomarker services play in pharmaceutical and biotech research. Our dedication to this aspect of drug discovery and development has positioned us as a leading provider of comprehensive solutions in the field. We channelize our expertise, technologies, and comprehensive service range to help identify and validate potential drug targets, thereby catalyzing your drug development process.
Our Services Include
We offer a vast array of services to meet the dynamic needs of drug discovery and development. These include Biomarker Identification and Validation, vital for ensuring the feasibility and potential success of a therapeutic candidate. We provide Tissue Analysis for Target Engagement and Expression and Drug-induced pathway activation analysis through Gene or Protein Expression/ Co-expression. We also study the Biological impact of therapeutics via on/off-target analysis of proteins, tissue and cell-based analysis, and multiplex/co-expression analysis. These services form the bedrock of our comprehensive preclinical biomarker services portfolio.